Healthcare
[WEBINAR] Biopharma Dealmaking 2026: Trends, Shifts, and What Comes Next
In this webinar, Ipsos will frame the latest dealmaking trends using recent transactions and market data, followed by a moderated discussion with active investors on what is changing in valuation, deal structures, and decision criteria, and what this means for pharma acquirers and innovator biotechs preparing for partnering conversations.
Patients
Survey
Fewer now rate the quality of their healthcare as good, hitting a new low for the PX Pulse tracker
Public opinion
Survey
Seniors’ support for allowing the government to negotiate drug prices drops significantly when shown various arguments for and against drug price negotiations
145 - 153 of 483 items